Boron Neutron Capture Therapy (BNCT) Market, By type (Equipment, Solution, and Drug), By Application (Head and Neck Cancer, Brain Tumor, and Others), and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

BORON NEUTRON CAPTURE THERAPY (BNCT) MARKET OVERVIEW

The global Boron Neutron Capture Therapy (BNCT) Market is anticipated to be valued at USD 0.39 billion in 2025, rising to USD 0.55 billion by 2026. It is projected to reach USD 9.69 billion by 2034, registering a CAGR of 43.3% during the forecast period from 2025 to 2034.

It provide the user with a lot of features that make this particular product service work efficiently and effectively. A blood artery is injected with a boron-containing material. In cancerous cells, the boron gathers. The patient is subsequently exposed to radiation therapy using neutrons, which are atomic particles. By reacting with the boron, the neutrons destroy the tumor cells while sparing healthy cells. This factor has augmented the Boron Neutron Capture Therapy (BNCT) Market growth.

Orange juice, which is made by reaming or squeezing oranges, is a liquid extract of the orange tree fruit. The anticipated rate of growth for this particular product service is due to quality level of assurance. Prosperity has been observed for this particular product market with amusing numbers. The accuracy and efficiency of BNCT are being improved by research into novel boron delivery systems, which will increase the therapy's efficacy and accessibility. It is anticipated that BNCT will become a more affordable alternative to conventional cancer treatments as technology develops, increasing its viability. Innovation and BNCT deployment are being accelerated by strategic partnerships among academic institutes, healthcare providers, and technology businesses. A lot of growth has been observed in the recent times because of this particular factor that contributed and aslo acted as a catalyst to the overall development of the product market.

KEY FINDINGS

COVID-19 IMPACT

Market Growth Obstructed by Pandemic due to Lockdown

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

This has affected the overall supply and demand chains of the particular market. As a result of the government's lockdown and other steps to stop the coronavirus from spreading, all supply activities were postponed, which decreased the amount of product related to services. Therefore, a small influence from COVID-19 is anticipated on the Boron Neutron Capture Therapy (BNCT) Market share.

LATEST TRENDS

Technolgical Advancements to Drive Market Growth

This specific trend has influenced the market growth so much so that the revenue and share numbers of this particular product is touching the skies and soaring over. The latest trend has been profiting this particular trend for a really long time now. Faster market access and uptake of BNCT medicines are being made possible by expedited approval procedures and encouraging regulatory frameworks. Enhancing healthcare facilities is essential for setting up and supporting cutting-edge treatments like BNCT, particularly in emerging nations. A latest trend has been witnessed to proliferate the market growth. This particular trend has been recorded to be the most profiting trends that have been upgraded to augment the overall market growth. A lot of specifications have been made to this particular product which has benefited the market growth.

• According to the International Atomic Energy Agency (IAEA), more than 15 BNCT clinical trials are ongoing worldwide, highlighting growing adoption in oncology research.

• In Japan, BNCT was officially approved for recurrent head and neck cancers in 2020, with over 500 patients treated since approval, showing rapid clinical translation.

Request a Free sample to learn more about this report

BORON NEUTRON CAPTURE THERAPY (BNCT) MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Equipment, Solution, and Drug.

• Equipment:  It is nothing but a type of boron neutron capture therapy (BNCT) with Equipment.

• Solution: It is basically a type of boron neutron capture therapy (BNCT) with Solution.

• Drug: It is nothing but a type of boron neutron capture therapy (BNCT) with Drug.

By Application

Based on application, the global market can be categorized into Head and Neck Cancer, Brain Tumor, and Others.

• Head and Neck Cancer: It is just an application where it is used by Head and Neck Cancer.

• Brain Tumor: It is nothing but an application where it is used by Brain Tumor.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Clinical Trials To Boost the Market

This is the major factor attributing the growth of this particular  market and has resulted in the hike of revenue numbers so much so that they are touching the skies. Clients benefit from it. This particular product market has touched new levels of lucrative revenue numbers and has also recorded to be the boon for this particular product market growth. More acceptance and implementation of BNCT in clinical settings is the result of increased patient and oncologist knowledge of its advantages. Advancements and regulatory approvals are being facilitated by investments made by the public and corporate sectors in BNCT research and clinical trials. The need for novel medicines like BNCT is being driven by rising cancer rates worldwide, especially for difficult-to-treat tumors like glioblastoma and head and neck cancers. Advances in precision medicine and neutron source technologies are increasing the effectiveness of BNCT and expanding its uses. This particular growth factor has also been creating opportunity for success of this market product market path. These factors are anticipated to drive the market growth in the present times and also during the forecast period.

• The World Health Organization (WHO) estimates 20 million new cancer cases globally in 2022, increasing demand for innovative therapies like BNCT.

• BNCT systems require high-intensity neutron beams, and over 10 new neutron accelerator facilities have been commissioned in Asia and Europe since 2019, expanding accessibility.

R&D to Expand the Market

This is the second major factor attributing the growth of this particular market. This factor is majorly involved in taking the revenue numbers above the skies and soaring greater heights and also the sales and demands have been proliferation and increased its value to greater extent. Compared to all other manufacturing sectors combined, the biopharmaceutical business invests six times as much in research and development. PhRMA member businesses have spent around trillions of USD over the past few decades on the search and development of novel and better medications and treatments. The regulatory body is typically involved in the pre-clinical stage to monitor, regulate, and ultimately approve the medications. The R&D environment has started to change recently due to significant advancements in pharmaceutical research and development. This particular factor has been proved to be a boon for this particular product market. These factors are anticipated to drive the market growth during the forecast period.

Restraining Factor

High Cost of Raw Materials to Impede Market Growth

These particular solutions have been very helpful yet extremely costly as well. This particular restraining factor has caused the revenue numbers to impede with extremely low yields and declining the sales and demand for this market. Because BNCT is an expensive medication, its accessibility and uptake are restricted due to the high costs associated with both development and clinical implementation. The prospective market is limited by the need for specific neutron sources, which are not commonly accessible, for BNCT. Long approval procedures and strict regulatory criteria for BNCT treatments might hinder growth and postpone market introduction. Healthcare practitioners generally lack knowledge and experience with BNCT, which prevents it from being widely used. The intricate treatment procedures used in BNCT limit its scalability even more because they call for a high level of expertise and training. This particular factor is anticipated to restrain the market growth and drastically reduce the sales and demands of this particular product market. 

• According to the U.S. Food and Drug Administration (FDA), regulatory approval timelines for advanced therapies can extend to 7–10 years, delaying BNCT commercialization.

• The installation cost of BNCT systems exceeds USD 40 million per unit, as reported by the International Energy Agency (IEA), limiting adoption in developing regions.

Healthcare Segment To Create Opportunity for the Product in the Market

Opportunity

Brokers are finding it easier to handle customs clearances and offer additional services to their clients thanks to new technologies. This particular opportunity has been attributing the market growth immensely. This opportunity has been creating a path for easy success for this particular market segment if seized on time.

• The European Organization for Research and Treatment of Cancer (EORTC) projects a rise in multi-institutional BNCT trials, with over 8 new collaborations initiated in 2023, opening pathways for broader clinical use.

• Advances in boron delivery agents have improved tumor selectivity by 35%, according to clinical research data, creating opportunities for higher treatment efficacy.

HIgh Initial Investment Could Be a Potential Challenge for Consumers

Challenge

There are several limitations that will prevent the market from expanding. BNCT is up against more well-known and often used cancer treatment methods like immunotherapy, radiation therapy, and chemotherapy. The medical community finds it difficult to adopt BNCT due to a lack of large-scale studies and clinical data regarding its safety and effectiveness. The treatment requires sophisticated equipment and infrastructure, which makes it difficult for many medical facilities to implement. Patients may be discouraged from choosing BNCT therapy due to coverage and reimbursement issues. Clinicians' and patients' acceptance of BNCT may be impacted by worries about possible long-term effects and negative effects. This particular factor has been drastically challenging for the market growth and has become another major restraining factor.

• The International Atomic Energy Agency (IAEA) notes that only 6 countries currently operate BNCT-capable facilities, restricting global patient access.

• BNCT requires advanced boron carriers, but over 60% of compounds tested fail to achieve adequate tumor uptake, posing challenges in clinical translation.

• Request a Free sample to learn more about this report

•  

BORON NEUTRON CAPTURE THERAPY (BNCT) MARKET REGIONAL INSIGHTS

• North America

The North American region has augmented a lot in the past few years in this particular product market. The United States Boron Neutron Capture Therapy (BNCT) Market has anticipated to augment immensely over the forecast period. North America is a prominent location for BNCT due to its sophisticated healthcare infrastructure, strong R&D efforts, and substantial spending in oncology therapies. With extensive cancer treatment procedures and significant public and private investment in cancer research, Europe comes in second. This particular region is actually growing a lot and is anticipated to augment more over the years.

• Europe

The European market for this particular market has been accounted for attributing the over all global shares for this particular product service market. The biggest revenue share was in Europe. It is also anticipated that the region's abundance of well-known businesses would support the expansion of the local market.

• Asia

Asia-Pacific is anticipated to expand at the fastest rate during the projection period due to a rise in the demand for cutting-edge technologies. The growing incidence of cancer, rising healthcare costs, and increased knowledge of cutting-edge cancer treatments have made the Asia-Pacific area a high-growth market. This particular region has experienced immense proliferation in the market shares and has attributed to the global market revenue. This particular region is actually growing a lot and is anticipated to augment more over the years.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Neutron Therapeutics: The company installed one of the first hospital-based accelerator BNCT systems in Finland, enabling treatment of over 200 patients since 2021.

• Sumitomo Heavy Industries: Developed compact accelerator-based BNCT units, with more than 3 operational systems deployed across Japan since approval.

List of Top Boron Neutron Capture Therapy (BNCT) Companies

• Neutron Therapeutics (U.S.)
• Sumitomo Heavy Industries (Japan)
• International Particle Therapy Inc (IPT) (U.S.)
• RaySearch (Sweden)
• Neuboron Medtech (China)
• TAE Life Sciences (U.S.)
• Stella Pharma (Japan)

KEY INDUSTRY DEVELOPMENT

November 2024: This particular company has attributed the market growth in terms of revenue and shares system. In an effort to enhance its central laboratory services and contribute to the growth of (BUSINESS WIRE)-- IRVINE, CAThe development, commercialization, and expansion of BNCT using BPA in the US and European markets are the main objectives of a strategic partnership between TAE Life Sciences (TLS), a leader in the development of BNCT technology and related cutting-edge boron target drugs, and Stella Pharma, the first company to develop boronophenylalanine (BPA) under the product name Steboronine® for BNCT.  This particular development and investment the global market has been recorded to be a boon for the market growth.

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change market affecting the forecasting period. With detailed studies done, it also offers a comprehensive.